Clinical trials
Anaphylaxis clinical trials
Below are recruiting anaphylaxis clinical trials, each written for real people, not researchers. We’re tracking 13 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07045701Enrolling by invitationPhase 2/Phase 3
Testing FMXIN002 for food allergy reactions
This study is testing a new medicine (FMXIN002) for people who are at risk of a severe allergic reaction to food. If you have a known food allergy and have had a moderate reaction during a food challenge, you may be able to join. The trial will check if the medicine helps prevent or reduce the severity of future reactions.
Be’er Ya‘aqovAges 18–40 - NCT03523221RecruitingPhase 1
Dexamethasone to prevent a second anaphylaxis reaction
This trial tests whether a dose of dexamethasone (a steroid medicine) can help stop anaphylaxis symptoms from returning after the first episode. It focuses on children with mild to moderate anaphylaxis in the emergency department.
DohaAges 3 months–14 years - NCT06793163Recruiting
Finding causes of severe allergic reactions during surgery
This study looks at what causes severe allergic reactions during surgery. It helps doctors find out which medicine or substance triggered the reaction, so they can avoid it in the future.
Beijing, Beijing MunicipalityAges 2 years+ - NCT07038746RecruitingPhase 1
Inhaled epinephrine for severe allergic reactions during tests or treatment
This trial tests if inhaled epinephrine can safely treat moderate to severe allergic reactions (grade 2 or higher) that can happen during allergy skin tests, oral food or drug challenges, or allergy shots. It is for people who have had such reactions in the past or are at risk and are planning to undergo one of these procedures.
Richmond, British ColumbiaAges 12 years+ - NCT04615065Recruiting
Biobank study collecting emergency data for very sick patients
This study collects health and sometimes blood sample information from people arriving at the emergency department with high-risk or serious conditions. The goal is to build a large emergency “biobank” to help researchers better understand and improve urgent care.
GroningenAges 18 years+ - NCT04653324Recruiting
Registry for people with diagnosed food allergies
This registry aims to collect information from people who already have a diagnosed food allergy. Joining may help researchers better understand food allergy patterns and needs.
McLean, VirginiaAges Any age - NCT05210543Recruiting
Study people after a severe allergic reaction
This trial follows people who have had anaphylaxis (a severe, life-threatening allergic reaction) within the last year. The goal is to better understand what happens over time so doctors can improve care.
BerlinAges Any age - NCT05695261RecruitingPhase 2
Oral microbiome capsules for peanut allergy in teens
This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.
Boston, MassachusettsAges 12–17 - NCT06406114RecruitingPhase 2
Better Allergy Testing for Cephalosporin Antibiotics
This study tests better ways to diagnose allergies to common cephalosporin antibiotics, like Keflex and Rocephin. By participating, you may learn if you are truly allergic to these medicines and if they are safe for you to take in the future.
Scottsdale, ArizonaAges 18–70 - NCT07328178Recruiting
Understanding IgE proteins in allergies and immune conditions
This study looks at IgE, a protein involved in allergic reactions, to better understand its role in different immune-related diseases. It aims to find out how different forms of IgE relate to health and disease, which may help improve diagnosis or treatment.
Leuven, Vlaams-BrabantAges 18 years+ - NCT07341776RecruitingPhase 4
Testing steroids for food allergy reactions
This trial tests whether using a steroid drug can help treat allergic reactions to food. If you have a food allergy that causes immediate symptoms (like hives or trouble breathing), this study may help find better ways to manage those reactions.
Basel, BaselAges 6 months–18 years - NCT07349212RecruitingPhase 1/Phase 2
Study of UKK-0018 for peanut allergy treatment
This trial tests a new immunotherapy called UKK-0018 to treat peanut allergies in adults. The goal is to help your body become less sensitive to peanuts over time.
Camperdown, New South WalesAges 18–55 - NCT07228325Enrolling by invitationPhase 1/Phase 2
Comparing a new epinephrine injector to EpiPen in adults with allergies
This study tests a new epinephrine auto-injector (FMXIN002) compared to the standard EpiPen in people with a history of hay fever or seasonal allergies. The goal is to see if the new device works just as well and is safe in a controlled clinic setting.
MississaugaAges 18–55
Hear when a new Anaphylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for anaphylaxis?
- Yes. Clin2 currently lists 13 recruiting anaphylaxis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a anaphylaxis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a anaphylaxis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.